Advertisement
Advertisement

MLYS

MLYS logo

Mineralys Therapeutics, Inc. Common Stock

29.54
USD
Sponsored
+0.19
+0.65%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

30.10

+0.56
+1.91%

Mineralys Therapeutics, Inc. Common Stock Profile

About

Mineralys Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. Mineralys Therapeutics Inc. is based in RADNOR, Pa.

Info & Links

CEO

Jon Congleton

Headquarters

150 N. RADNOR CHESTER ROAD, SUITE F200
RADNOR, PA 19087, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.mineralystx.com

Auditor

Ernst & Young LLP

Share holders

5

Employees

76

Mineralys Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

2.48B

Enterprise Value

2.37B

Enterprise Value/EBITDA(ttm)

-13.83

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

3.33

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-32.94%

Return on Invested Capital(ttm)

-37.55%

Return on Assets(ttm)

-31.68%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-171.45M

Net Income Available to Common(ttm)

-151.78M

Diluted EPS(ttm)

-2.37

Share Statistics

Beta (5Y Monthly)

0.69

52-Week Change

89.24%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

82.50M

Dividend Yield

0.00%

Float4

61.34M

% Held by Insiders

25.56%

% Held by Institutions

84.46%

Balance Sheet

Total Cash(mrq)

646.06M

Total Cash Per Share(mrq)

7.83

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

43.76%

Quick Ratio(mrq)

43.76%

Book Value Per Share(mrq)

7.93

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.10

Free Cash Flow(ytd)

-142.43M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement